BESREMi® (Ropeginterferon alfa-2b) deemed safe and efficacious by the US FDA
BESREMi® (Ropeginterferon alfa-2b) deemed safe and efficacious by the US FDA BESREMi® (Ropeginterferon alfa-2b) deemed safe and efficacious by the US FDA Wien (pts026/15.03.2021/15:15) - The US Food & Drug Administration (FDA) issued a complete response letter for the drug BESREMi® with the active pharmaceutical ingredient Ropeginterferonalfa-2b, in which the FDA confirms the efficacy and safety of the drug. This assessment was based on the clinical development program by the European r...
United States Nina Roth Rudolf Widmann Forschung Entwicklung Pharmaceuticals Aktiengesellschaft Us Food Drug Administration
Source: pressetext.com